#Zoledronic Acid industry | Explore Tumblr posts and blogs

ipharmacyeg-blog · 26 days ago

Text

Oprasta: The Affordable Local Alternative to ACLASTA® for Bone Health

Looking for an affordable bone health treatment? Oprasta is a cost-effective local alternative to ACLASTA®, offering the same effective zoledronic acid at just $24. Manufactured by Pharco Pharmaceuticals, it's available easily in Egypt. #Oprasta #Zoledron

In the pharmaceutical industry, having access to local alternatives to internationally recognized products is crucial for improving patient care. One such local alternative is Oprasta, a medication produced by Pharco Pharmaceuticals, a well-established Egyptian pharmaceutical company. This article will compare Oprasta with the international brand ACLASTA®, focusing on key differences in cost,…

#DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION #DRUGS FOR TREATMENT OF BONE DISEASES

0 notes

wellnessweb · 7 months ago

Text

Osteoporosis Treatment Market Size: Growth Factors and Key Drivers

The Osteoporosis Treatment Market size was estimated at USD 13.28 billion in 2023 and is expected to reach USD 18.59 billion By 2031 at a CAGR of 4.3% during the forecast period of 2024-2031.The osteoporosis treatment market is witnessing significant growth, driven by the aging global population and increasing prevalence of the condition. Advances in pharmaceutical research have led to the development of innovative therapies, including bisphosphonates, selective estrogen receptor modulators (SERMs), and monoclonal antibodies like denosumab, which are enhancing patient outcomes. Additionally, the market is expanding with the integration of digital health technologies and personalized medicine approaches, offering tailored treatment plans that improve adherence and efficacy. Rising awareness campaigns and government initiatives aimed at early diagnosis and management of osteoporosis further bolster market dynamics, ensuring a robust pipeline of new treatments and supportive care strategies.

Get Sample of This Report @ https://www.snsinsider.com/sample-request/3337

Market Scope & Overview

Potential customers, sales and competitive environment studies, planned product releases, existing and novel technological advancements, revenue and trade regulatory evaluations, and more are all covered by the Osteoporosis Treatment Market research. The purpose of the study is to give participants a chance to comprehend the most recent trends, the state of the market, and market-related technology.

As per the market research there are new and quickly growing market segments, geographical areas, market drivers, challenges, and opportunities in the global Osteoporosis Treatment industry. The research report covers significant market strategies, long-term objectives, increasing market share, and product portfolios of top companies. Additionally, it helps venture capitalists make wise decisions by helping them comprehend organizations better.

Market Segmentation Analysis

By Drug Class

Calcitonin

Bisphosphonate

Zoledronic Acid

Ibandronate

Alendronate

Risedronate

Other

Hormone Replacement Therapy

RANK ligand (RANKL) Inhibitor

Parathyroid Hormone-Related Protein (PTHrP) Analog

Selective Estrogen Receptor Modulator (SERMs)

By Administration

Injectables

Oral

Others

By Distribution Channel

Online Pharmacies

Retail Pharmacies & Stores

Hospitals Pharmacies

Russia-Ukraine Conflict Impact on Osteoporosis Treatment Market

The market research demonstrates how the conflict between Russia and Ukraine has impacted markets around the globe. Additionally, it provides guidance to market participants on how to create practical solutions to lessen the negative effects of such contradictory circumstances.

Regional Outlook

The latest market study examines a wider range of topics and looks at the situations and events that are most likely to have a lasting impact. These elements, also referred to as market dynamics, include the pressures, constraints, choices, and issues that shape how those elements are viewed. The main geographical areas covered by the Osteoporosis Treatment Market research report are North America, Latin America, Asia Pacific, Europe, the Middle East, and Africa.

Competitive Analysis

The global market research report's section on competition analysis examines a few key players in the Osteoporosis Treatment Market. The research report also covers supply-chain analysis, market expansion strategies, a PEST analysis, a Porter's Five Forces analysis, and market-like scenarios.

Major Questions Answered in Osteoporosis Treatment Market Report

What production values, outputs, and capabilities can be anticipated for the global industry?

What entry strategy, cost-cutting measures, and distribution plans should the market have?

What impact has the conflict between Russia and Ukraine had on the target audience?

Conclusion

Understanding the information contained in the Osteoporosis Treatment Market research report is necessary in order to grasp the current state and potential futures of the industry.

About Us

SNS Insider is a market research and insights firm that has won several awards and earned a solid reputation for service and strategy. We are a strategic partner who can assist you in reframing issues and generating answers to the trickiest business difficulties. For greater consumer insight and client experiences, we leverage the power of experience and people.

When you employ our services, you will collaborate with qualified and experienced staff. We believe it is crucial to collaborate with our clients to ensure that each project is customized to meet their demands. Nobody knows your customers or community better than you do. Therefore, our team needs to ask the correct questions that appeal to your audience in order to collect the best information.

Related Reports

Diabetic Neuropathy Market Trends

Smart Contact Lenses Market Size Trends

Lymphoma Treatment Market Trends

Veterinary Vaccine Adjuvants Market Trends

Medical Electrodes Market Trends

0 notes

damngoclam11 · 9 months ago

Text

Thuốc Ozumik 4mg/5ml Axit zoledronic điều trị tăng canxi huyết do ung thư

Thuốc Ozumik 4mg/5ml chứa hoạt chất chính acid zoledronic là thuốc dùng trong điều trị tăng canxi huyết do ung thư, gãy xương bệnh lý ở bệnh nhân ung thư, ung thư xương. Đây là một sản phẩm của công ty Demo S.A. Pharmaceutical Industry – Hy Lạp.

Thông tin cơ bản của thuốc Ozumik 4mg/5ml

Tên thương mại: Ozumik 4mg/5ml

Hàm lượng: 4mg/5ml

Thành phần chính của thuốc Ozumik: Axit zoledronic

Dạng bào chế: Dung dịch đậm đặc dùng để tiêm truyền.

Quy cách : Hộp 1 lọ có chứa 5ml.

Hãng sản xuất: Công ty Demo S.A. Pharmaceutical Industry – HY LẠP

https://thuockedon24h.com/thuoc-ozumik-4mg-5ml-axit-zoledronic-dieu-tri-tang-canxi-huyet-do-ung-thu/

0 notes

gmr2 · 1 year ago

Text

0 notes

marketresearchblogimr · 3 years ago

Text

What is zoledronic acid monohydrate used for?

According to this latest study, the growth in the Zoledronic Acid market will change significantly from the previous year. Over the next five years, Zoledronic Acid will register a CAGR in terms of revenue, and the global market size will reach USD in millions by 2028.

According to the recent report published by Introspective Market Research, the Global Zoledronic Acid Market report provides sustainable growth opportunities, challenges, scope, Driver restraints, and the latest trends during the forecast period from 2022 to 2028. This latest industry research study analyses the Zoledronic Acid market by various product segments, applications, regions, and countries while accessing the regional performances of numerous leading market participants. In this report, there are various approaches and procedures approved by key market players that enable efficient business decisions.

Our Research Study provides up-to-date, detailed data on the dynamics of the Global Zoledronic Acid market, providing marketers with the essential data they need to understand their and their competitors' position in the market, as well as information to accurately identify where they will compete in the future. Also, the report examines the components of market change by looking at past and future growth patterns, including the impact of consumer behavior on total quantity, value, selected brands, and selected product types.

Download FREE Sample Report @ https://introspectivemarketresearch.com/reports/14442

Target Audience of Market Zoledronic Acid:

Manufacturer / Potential Investors

Traders, Distributors, Wholesalers, Retailers, Importers, and Exporters.

Association and government bodies.

Key Players Mentioned in the Market Zoledronic Acid Research Report:

Natco Pharma Ltd.,Taj Pharmaceuticals Ltd,Mustafa Nevzat,Teva Pharmaceutical Industries Ltd,CIPLA Ltd,MYLAN,ScinoPharm Taiwan Ltd.,Gador S.A.,Tecoland Corp.,Emcure Pharmaceuticals,Aosaikang Pharm,Nanjing Pharm,Lianyungang Runzhong Pharm,Hangzhou Longshine Bio-Tech

This Zoledronic Acid Market report covers important market segments on the basis of type, application, and region. The regional analysis segment includes key regions such as Europe, North America, the Middle East, Africa, and the Asia Pacific. It shows important business metrics including population density, quality, development, and overall market scenarios. It also discusses important data covering key industry topics such as market expansion and market situation developments. This in-depth Zoledronic Acid market report also sheds light on important technologies and helps organizations better understand their customers’ buying habits. It shows the global market scenario for the forecast period 2022-2028

Zoledronic Acid Market Segmentation

The report surveys the presence of the distinctive market segment a global as well as the regional scale that defines the Zoledronic Acid market size, demands and growth opportunities, and market areas that need to work on.

Zoledronic Acid Market Segment by Types, Estimates, and Forecast by 2028

Product 1, Product 2

Zoledronic Acid Market Segment by Applications, Estimates, and Forecast by 2028

injection

The regional market analysis Zoledronic Acid can be represented as follows:

This part of the report assesses key regional and country-level markets on the basis of market size by type and application, key players, and market forecast.

The base on geography, the world market of Zoledronic Acid has been segmented as follows:

North America includes the United States, Canada, and Mexico

Europe includes Germany, France, UK, Italy, Spain, Russia, and the Rest of Europe

South America includes Brazil, Argentina, Nigeria, Chile, and South America

The Asia Pacific includes Japan, China, South Korea, Australia, India, Rest of Europe

Pre-Book Now with 10% Discount on the Zoledronic Acid Market Report @: https://www.introspectivemarketresearch.com/discount/14442

Competitive Analysis

Today, the Platform as a Zoledronic Acid industry is making extremely large strides, having tough competition. Dominant players listed in the report covers companies, product, organization, popular brands, and such group that has the highest sales revenue percentage of the Zoledronic Acid industry, also who is the largest producer in the world?

#Zoledronic Acid Market size #Zoledronic Acid Market forecast #Zoledronic Acid Market share #Zoledronic Acid Market growth #Zoledronic Acid industry #Zoledronic Acid industry size #Zoledronic Acid

0 notes

pujarathod · 3 years ago

Text

Zoledronic Acid Market Report | Global Forecast From 2022 To 2028

Zoledronic Acid Market Share, Size, Growth, Trends, & Industry Forecast Analysis Report, By Type, Application and Regional Segment Forecast, 2022 - 2028, provides an extensive analysis of current market dynamics and predicted future trends.

According to this latest study, the growth in the Zoledronic Acid market will change significantly from the previous year. Over the next six years, Zoledronic Acid will register a CAGR in terms of revenue, and the global market size will reach USD in millions by 2028.

Zoledronic Acid Market is a research-based, top-to-bottom corporation. The study provides information on the overall business perspectives that influence market growth between the years 2022 and 2028. It provides information on the essential business models in this area. The market improvement potential, benefit, market interest, and development prospects are all included in the research. The study provided thoroughly verified and trustworthy data on the worldwide Zoledronic Acid market. Future projections, development prospects, major markets, and key stakeholders.

The Market Share Analysis examines suppliers in terms of their contribution to the entire market. It gives a sense of how much income it generates in comparison to other suppliers in the space. It provides information on how suppliers compare to one another in terms of revenue creation and client base. For the base year, knowing market share gives you an indication of the size and competitiveness of the suppliers. It reflects the market's accumulation, fragmentation, dominance, and amalgamation features.

Request Sample Copy@:

https://introspectivemarketresearch.com/request/14442

Leading Key Players Covered in Zoledronic Acid market:

· Natco Pharma Ltd.

· Taj Pharmaceuticals Ltd

· Mustafa Nevzat

· Teva Pharmaceutical Industries Ltd

· CIPLA Ltd

· MYLAN

· ScinoPharm Taiwan Ltd.

· Gador S.A.

· Tecoland Corp.

· Emcure Pharmaceuticals

· Aosaikang Pharm

· Nanjing Pharm

· Lianyungang Runzhong Pharm

· Hangzhou Longshine Bio-Tech

Introspective Market Research offers a comprehensive overview of the market through the analysis of key parameters such as revenue, price, competition, and promotions, as well as the study, synthesis, and summarization of data from different sources. It analyzes the leading industry drivers and shows numerous market components. The information offered is thorough, dependable, and the result of a comprehensive primary and secondary study. Introspective Market Research reports offer a comprehensive global market as well as an in-depth strategic sourcing methodology and analysis based on qualitative and quantitative research to anticipate market growth.

Customized Report @:

https://introspectivemarketresearch.com/custom-research/14442

The study aids in offering a more comprehensive overview of the industry as well as dealing with the precise research methodology used to calculate market size and projections. The secondary data sources are utilized, as well as the primary inputs required for data validation. This section also aids in the outline of the many segments that have been discussed as part of the report. Furthermore, Research Methodology assessments frequently include calculations for establishing global market inclinations.

Segmentation of Zoledronic Acid market:

By Type:

· Injection

· Powder

By Application:

· Injection

· Metastatic Bone Cancers

· Systemic Metabolic Bone Diseases

If You Have Any Query of Zoledronic Acid Market Report, Visit:

https://introspectivemarketresearch.com/inquiry/14442

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.

Geographic Segment Covered in the Report

· North America (U.S., Canada, Mexico)

· Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)

· Asia-Pacific (China, India, Japan, Southeast Asia, Rest of APAC)

· Middle East & Africa (GCC Countries, South Africa, Rest of MEA)

· South America (Brazil, Argentina, Rest of South America)

The report provides insights on the following pointers:

· Market Penetration: Provides comprehensive information on the market offered by the key players

· Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

· Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

· Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

· Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

Pick Up This Reports: -

https://introspectivemarketresearch.com/checkout/?user=1&_sid=14442

#Zoledronic Acid Market Zoledronic Acid Market Size Zoledronic Acid Market Share Zoledronic Acid Market Growth Zoledronic Acid Market Trend Z

0 notes

rajyog7493 · 3 years ago

Text

How Impacted COVID-19 on Zoledronic Acid ?

Impact of COVID-19 on Zoledronic Acid in Chemicals and Materials Industry

The COVID-19 pandemic has influenced the whole planet with its major impacts on the economy and businesses across the globe. The COVID-19 spread worldwide in unprecedented ways due to its high infectious and contagious nature and lack of availability of its vaccine. As a result, the greatest medical challenge in the 21st century is yet to be faced by physicians worldwide. Though the emergence of the virus can be traced back to Asia, many European countries along with the U.S. have been struck massively by the pandemic. The virus has spread across all regions ranging from North America, Europe, Asia-Pacific, Middle East, and Africa up to South America. The COVID-19 has been declared as a pandemic by World Health Organization (WHO) due to its increased spread across the globe. After the declaration of the pandemic, various countries announced the complete lockdown such as India, China, and other Asian countries to decrease its spread. According to the latest situation report by World Health Organization (WHO), 175 million cases of the corona have been reported globally and 4 million patients are dead due to the coronavirus. On a slightly positive note, a total of 158 million people have recovered and total of 2 million vaccine doses have been administered as well.

The pandemic have affected the Zoledronic acid market in three ways, that is, by directly affecting production and demand, by creating supply chain and market disruption and by its financial impact on firms and financial markets.

Zoledronic acid is a bisphosphate drug that reduces bone loss and treats bone complications such as low bone density. The acid is majorly used for the treatment of hypercalcemia, prevention of bone fracture, and other bone-related indications. The major factors contributing for the growth of the market are rise in prevalence of cancer, trend of sedentary lifestyle, increase in obesity cases, and smoking leading to bone complications. However, owing to the current COVID-19, there has been disrupting and delaying of many patients with bone diseases.

For instance,

· In April, 2020 American Society for Bone and Mineral Research (ASBMR) set up a steering committee of bone specialist to manage the treatment of targeted bone disorders amid pandemic.

The pandemic has negatively impacted the Zoledronic acid market as pharmaceutical companies witnessed a setback in the supply chain management owing to imposition of lockdown by government. The lockdown has also impacted orthopedic appointments negatively as it is crucial to have a physician’s consultation for bone complications and other conditions.

STRATEGIC INITIATIVES BY KEY PLAYERS

As the reality of COVID-19 dawned upon the world, manufacturing and production unit of companies involved Zoledronic acid key players formed strategies so as to mitigate with the limitations occurred due to the virus and keep their business running.

At the individual company level, companies are now more focused on operational resilience and accelerating initiatives that enable more agility, and transparency through greater deployment of analytical tools and automation. Companies are considering re-evaluating their strategies, risk tolerance and overall footprint.

For instance,

· In September, 2020 a retrospective study was conducted by Journal on oncology in china to check the safety profile of Zoledronic acid. The study aimed to investigate whether the long-term ZA treatment had greater benefits than short-term in patients.

However, to address the crisis all companies in this market are revisiting their financial trajectories and framing new strategies that will lead to bring out solutions in the market resulting in increased business efficiency.

IMPACT ON PRICE

Due to the pandemic, the market is disturbed to a very big level. The several establishments has to remain shut while others to scale down or put on hold expansion plans as they tried to survive the unprecedented crisis.

Due to the impact of the coronavirus, many large pharmaceutical companies have placed new trials on hold and numerous small, mid-size, and large enterprises have suspended ongoing ones, thereby demonstrating the magnitude of the disruption.

There have been uncertain past months due to the emergence of COVID-19. The sale of some company’s products experienced a downfall while others managed to stay afloat.

For instance,

· According to the annual report of Dr. Reddy’s Laboratories the sale of its products increased from USD 1,538.51 million in 2019 to USD 1,746 million in 2020.

· According to the annual report of Abbott Laboratories (2020), the sale of products saw increase in the sales. The revenue was USD 3791, 89 million in 2019 which increased to USD 4207, 53 million in 2020.

IMPACT ON DEMAND

With the lockdown all orthopedic appointments were discontinued as they are medically unnecessary.

Since the pandemic, lockdown situation the economic growth of country is declining. And the manufacturing units for various items that are considered non-essential are shut down due to the non-availability of manpower.

The pandemic has caused major destruction in the delivery of the healthcare products across the world. It has posed limitations on many patients to access standard health services such as visits to healthcare professionals, medications and diagnosis. It has adversely impacted the ability of patients and practitioners to adhere to treatment guidelines. Moreover, the demand for Zoledronic acid and growing awareness about current and new products is also fueling the market.

For instance,

· Dr. Reddy’s Laboratories Ltd, which is one of the key producer of Zoledronic acid and its financial performance for the twelve-month period ended 31 December, 2020 stated that they have experienced both negative and positive impacts of the pandemic but overall operations and product demand remained very stable and strong.

However, the negative impact of the pandemic on Zoledronic acid market will be soon mitigated as different states/ countries allow medical clinics to reopen, services and once again being offered.

IMPACT ON SUPPLY CHAIN

As the world came to halt in the last few months due to the emergence of pandemic, the supply chain couldn’t escape the impact. The government throughout the globe imposed total lockdown which led to supply chain disruptions. Consequently, the supply chain came to standstill due to the closure of borders. Even though the demand for Zoledronic acid remained untouched up to an extent, the availability was affected due to disruption in supply chain, trade and travel restrictions. Supply of raw material, was also affected, due to which the production was effected.

The outsourcing services which are providing warehousing, storage and other services face challenges too. They are totally dependent on the logistic and transportation of chemical compound raw material from the outsourced service to the researchers desk. However, the sudden shut down globally with ban in travel this process get disrupted. Still the companies managed to overcome the challenges and saw high growth.

For instance,

· Abbott Laboratories continuously kept the close contact with suppliers and customers to mitigate any delays arising from stretched supply chain.

They are in constant communication with their manufacturing supply chain to keep up the supply of products for their customers.

However, the companies have been faced with substantial business and operational disruptions, which includes everything from mitigating the effects of reduced supply, to managing disruptions to logistics suppliers, and indeed hurdles in meeting their own contractual obligations to customers.

The pandemic have forced the companies to rethink their supply chains and their stability and reliability for an uncertain future, including other externalities and government actions through the world, which begun impacting supply chains, such as issues of sustainability.

CONCLUSION

COVID-19 has impacted each and every sector with global Zoledronic acid market being no exception as it has been affected the same. Different companies dealing in Zoledronic acid has been finding out their own way to deal with this pandemic situation. The government and companies around the globe are working together and have issued advice for those undergoing treatment for bone complications during these unprecedented times during COVID-19 lockdown around the world.

However, in the crisis call pharmaceuticals, key players, government bodies and healthcare organizations are working closely with healthcare professionals, customers, and patients for betterment of public health. Thus, it is reasonable to assume that constraints on gathering and movement have disproportionally impacted people who use Zoledronic acid.

Moreover, healthcare industries and government bodies are exclusively concentrating on how they can make effective and best contribution to control the spread of the virus and save lives. They are also ramping up production of essential medicines to new levels and ensure that the speed doesn’t affect or destroy the quality of products.

#Zoledronic Acid Market by Type #Zoledronic Acid Market Future Innovation #Zoledronic Acid Market

0 notes

marketgrowthreseach · 3 years ago

Photo

Industry Growth Insights published a new data on “Zoledronic Acid Market”. The research report is titled “Zoledronic Acid Market research by Types (Injection, Powder), By Applications (Metastatic Bone Cancers, Systemic Metabolic Bone Diseases), By Players/Companies Mylan, Eli Lilly, Pfizer, Apotex, Teva, Amgen, Tecoland, Novartis, Emcure Pharma, Taj Pharmaceuticals, Natco Pharma, Scinopharm Taiwan, Lianyungang Runzhong Pharmaceutical, Hangzhou Longshine Bio-Tech”.

More Details: https://industrygrowthinsights.com/report/zoledronic-acid-market-2/

0 notes

newsinsights · 3 years ago

Text

Hypercalcemia Treatment Market is Projected to gain CAGR of 11.2% by forecast year 2026

This report by Future Market Insights (FMI) examines the ‘Hypercalcemia Treatment Market’ for the Forecast period. The primary objective of the report is to offer updates and information related to market opportunities in the global hypercalcemia treatment market.

The global hypercalcemia treatment market report begins by defining hypercalcemia treatment and various types of products used in hypercalcemia treatment. It is followed by an overview of market dynamics of the global hypercalcemia treatment market, which includes FMI’s analysis of key trends, drivers, restraints and opportunities that are influencing growth of the global hypercalcemia treatment market. Impact analysis of key growth drivers and restraints based on a weighted average model have been included in the global hypercalcemia treatment market report after detailed analysis of individual regions to better equip readers with meaningful insights on ongoing developments in the market.

Primary factors fuelling demand for hypercalcemia treatment include increasing prevalence of hyperparathyroidism-related hypercalcemia, increasing number of patients with cancers, higher incidence of multiple myeloma, availability of appropriate drug therapy alternative over surgery, favourable reimbursement scenario and drug therapies to avoid kidney failure. However, primary factors hampering growth of the hypercalcemia treatment market are patient location, hypercalcemia drug adoption and cost recovery from limited patient population.

Based on product type, the market has been segmented bisphosphonates (clodronate, etidronate, ibandronate, pamidronate and zoledronic acid), calcitonin, glucocorticoids, denosumab and calcimimetics. A detailed analysis has been provided for these segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.

Request For Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1320

Based on distribution channel, the market has been segmented into hospitals, clinics and independent pharmacy and drug stores. Our analysis predicts that revenue form the independent pharmacy and drug stores segment will expand at a relatively fast pace, and the segment is expected to contribute significantly towards the distribution of hypercalcemia drugs during the forecast period. Hospitals distribution channel segment is projected to generate comparatively high revenue owing to novel and easy availability of hypercalcemia treatment drugs worldwide.

The next section of the report highlights hypercalcemia treatment market by region and provides market outlook for 2016–2026. The report also discusses key regional trends contributing to revenue growth of the global hypercalcemia treatment market, as well as analyses the impact of drivers and restraints in each region. Key regions assessed in this report include North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), Japan and the Middle East & Africa (MEA).

The above sections - by product type, distribution channel and region — evaluate the present scenario and growth prospects of the hypercalcemia treatment market for 2016–2026. We have considered 2015 as the base year and provided data for the forecast period, i.e., 2016–2026.

To ascertain hypercalcemia treatment market size, we have also considered revenue generated by companies operating in the hypercalcemia treatment market space. The forecast presented here assesses the total revenue by value across the hypercalcemia treatment market. In order to offer an accurate forecast, we started by sizing the current market, which forms the basis of how the hypercalcemia treatment market is expected to develop in future. Given the characteristics of the market, we triangulated the outcome of three different types of analysis based on supply side, downstream industry demand and the economic envelope.

In addition, it is imperative to note that in an ever-fluctuating global economy, we not only conduct forecast in terms of CAGR, but also analyse on the basis of key parameters such as Year-on-Year (Y-o-Y) growth rates. This is imperative to understand the predictability of the market and to identify the right opportunities across the global hypercalcemia treatment market.

The hypercalcemia treatment market has been segmented on the basis of product type, distribution channel and region. These segments are analysed in terms of Basis Point Share (BPS) to understand each individual segment’s relative contribution to market growth. This detailed level of information is important for identifying various key trends in the global hypercalcemia treatment market.

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is normally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective.

To understand key segments in terms of growth and adoption for hypercalcemia treatment drugs globally, FMI has developed the hypercalcemia treatment market ‘Attractiveness Index’. The resulting index is expected to help providers identify real market opportunities in the global hypercalcemia treatment market.

In the final section of the report on the global hypercalcemia treatment market, ‘Competitive Landscape’ is included to provide report audiences with a dashboard view, based on categories of drug developers in the hypercalcemia treatment market space and key differentiators. Key categories of providers covered in the report are companies developing hypercalcemia treatment drugs. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the hypercalcemia treatment value chain and the potential players for the same. Report audiences can gain segment-specific company insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in hypercalcemia treatment marketplace.

Detailed profiles of the hypercalcemia treatment developing companies are also included in the scope of the report to evaluate their long- and short-term strategies, key offerings, SWOT analysis and recent developments in the global hypercalcemia treatment market.

Key companies covered in report are Bayer Pharma AG, Sun Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Amgen Inc., Novartis AG, Dr. Reddy’s Laboratories Ltd. and Cipla Inc.

Any Queries, Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1320

Key Segments Covered

Clodronate

Etidronate

Ibandronate

Pamidronate

Zoledronic acid

Hospitals

Clinics

Independent Pharmacy and Drug Stores

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies

Detailed insights of market segments and sub-segments for historical as well as forecast period

A competitive analysis of prominent players and emerging players in the Hypercalcemia Treatment Market

Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact

Mr. Abhishek Budholiya

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,

Jumeirah Lakes Towers, Dubai,

United Arab Emirates

MARKET ACCESS DMCC Initiative

For Sales Enquiries: [email protected]

For Media Enquiries: [email protected]

#Hypercalcemia Treatment Market

0 notes

swanandcmiprs · 4 years ago

Text

ANTI-OSTEOPOROSIS & FRACTURE HEALING MARKET ANALYSIS (2018-2026)

Osteoporosis involves a condition, which results when the rate of bone tissue regeneration is much less than its breakdown, making the bones porous. Osteoporosis is more prevalent in female, where more cases occur after menopause due to decrease in estrogen hormone levels. In osteoporosis, the strength and structure of bones is affected, which increases the probability of occurrence of fractures, especially in hip region, wrists, and spine. An X-ray based scanning method, Dual Energy X-ray Absorptiometry (DEXA) or bone densitometry, is used for diagnosis of the condition. Osteoporosis has no clear symptoms, although is characterized by spine weakening and joint pain.

Anti-Osteoporosis and Fracture Healing Market Drivers

In the recent past, various regulatory bodies such as European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), Medicines and Healthcare Products Regulatory Agency (MHRA), and others approved new drugs for treatment of osteoporosis. Approval and launch of such new drugs are expected to drive global Anti-Osteoporosis and Fracture Healing Market growth over the forecast period. For instance, in April 2017, Radius Health Inc., a biopharmaceutical company, received approval from U.S. Food and Drug Administration (FDA) for TYMLOS (abaloparatide) injection, for treating postmenopausal women with osteoporosis who are at high risk of fracture. This drug reduces the occurrence of spinal cord and peripheral skeleton fractures in postmenopausal women.

Furthermore, key players are launching new treatment methods for osteoporosis in the market. For instance, in January 2016 Ahn-Gook Pharmaceutical Co., Ltd., a South Korea based pharmaceutical company, received approval from the Korean Ministry of Food and Drug Safety (MFDS) for marketing of Binosto buffered alendronate in Korea. Alendronate reduces bone loss and buffering reduces the exposure of stomach and esophagus to acidified alendronate. Such new product launches are expected to fuel global Anti-Osteoporosis and Fracture Healing Market growth over the forecast period.

Anti-Osteoporosis and Fracture Healing Market Regional Analysis

North America anti-osteoporosis and fracture healing market is expected to witness significant growth over the forecast period owing to new product launches. For instance, in September 2018, Zydus Pharma Inc. received approval from U.S. Food and Drug Administration (FDA) for launch of Risedronate Sodium delayed release tablets in America, a drug used for osteoporosis treatment in postmenopausal women.

In April 2018 Amgen Inc., an American biopharmaceutical company, received approval from Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for marketing of Prolia (denosumab) in Europe. Denosumab is used for treating bone loss associated with prolonged systemic glucocorticoid therapy in patients who are at increased risk of fracture. This is expected to drive the Europe anti-osteoporosis and fracture healing market growth over the forecast period.

In January 2018 Amgen Inc. and UCB S.A announced receiving approval for marketing of Evenity (romosozumab) drug in Japan by Japanese Ministry of Health, Labor and Welfare. Evenity is a bone forming agent which performs dual role of increasing bone formation and reducing bone resorption leading to reduced risk of fracture. These factors are expected to support global Anti-Osteoporosis and Fracture Healing Market growth over the forecast period.

Anti-Osteoporosis and Fracture Healing Market Restraints

Bisphosphonate pills, a commonly used medication for osteoporosis are not well absorbed in the stomach and are involved with side effects such as stomach upset and heartburn. In addition to this, increased awareness regarding osteoporosis, especially in women, has resulted in consumption of calcium and vitamin rich diet and adapting physiotherapeutic measures for prevention of occurrence of osteoporosis. These factors are expected to restrain global Anti-Osteoporosis and Fracture Healing Market growth over the forecast period.

Anti-Osteoporosis and Fracture Healing Market Key Players

Some of the key players operating in the anti-osteoporosis and fracture healing market are Radius Health Inc., Pfizer Inc., Amgen Inc., Novartis AG, GlaxoSmithKline Plc., Merck & Co., Inc., F. Hoffman-La Roche AG, Eli, Lilly and Company Limited, and PhytoHealth Corporation.

Anti-Osteoporosis and Fracture Healing Market Taxonomy

The global Anti-Osteoporosis and Fracture Healing Market is segmented on the basis of drug class, route of administration, distribution channel, and regions.

By Drug Class

Bisphosphonates

Hormone replacement therapy

Monoclonal antibodies

Anabolic agents

Others

Alendronate (Fosamax)

Risedronate (Actonel)

Ibandronate (Boniva)

Zoledronic acid (Reclast)

Estrogen

Progestin

Others

Denosumab (Prolia)

Romosozumab (Evenity)

Alendronate (Fosamax)

Teriparatide (Forteo)

By Route of Administration

Oral

Injection

By Distribution Channel

Hospital pharmacies

Retail pharmacies

Online pharmacies

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Get sample report here: https://www.coherentmarketinsights.com/insight/request-sample/2525

Download PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2525

Buy now the market research report here: https://www.coherentmarketinsights.com/insight/buy-now/2525

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

• Customized Market Research Services

• Industry Analysis Services

• Business Consulting Services

• Market Intelligence Services

• Long term Engagement Model

• Country Specific Analysis

Explore CMI services

Contact Us:

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email: [email protected]

Source: https://www.coherentmarketinsights.com/ongoing-insight/anti-osteoporosis-and-fracture-healing-market-2525

0 notes

shruticmi · 4 years ago

Text

The global hypercalcemia treatment Market to grow at US$ 28,060.0 Mn by the end of 2028.

Summary:The global hypercalcemia treatment market to lead the market during forecast period with market valuation of US$ 10,696.6 Mn in 2018.

Description:

Hypercalcemia is a condition in which you have too high a concentration of calcium in your blood.However,too much of any intake it can cause problems to human body.Hypercalcemia makes it hard for the body to carry out its normal functions. Extremely high levels of calcium can be life-threatening.So,Treatment depends on the severity of symptoms and the underlying cause.

Key Trends:

Increasing prevalence of cancer is also expected to aid in growth of the market. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018.

The global Hypercalcemia Treatment market is expected to witness high growth during the forecast period.The report provides key statistics on the market status of the leading Hypercalcemia Treatment market players and offers key trends and opportunities in the market.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-pdf/3504

North America region held dominant position in the global hypercalcemia treatment market in 2018, accounting for 45.5% share in terms of value, followed by Europe.

Geographical Analysis:

The Hypercalcemia Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region. The Hypercalcemia Treatment market anticipated in five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America.

Competitive Landscape:

Major players operating in the global hypercalcemia treatment market include,Bayer Pharma AG, Sun Pharmaceutical Industries Ltd., Mylan N.V., Pfizer Inc., Amgen Inc., Novartis AG, Dr. Reddy’s Laboratories Ltd., Cipla Inc., and XOMA Corporation.

Buy this Research Report @https://www.coherentmarketinsights.com/insight/buy-now/3504

Market Segmentation:

· By Drug Class

o Bisphosphonates

o Clodronate

o Etidronate

o Ibandronate

o Pamidronate

o Zoledronic acid

o Calcimimetic Agents

o Calcitonin

o Denusomab

o Glucocorticoids

o Pipeline Analysis

· By Distribution Channel

o Direct Tenders

o Retail

· By Application

o Mild Hypercalcemia

o Moderate Hypercalcemia

o Severe Hypercalcemia

· By End User

o Hospitals

o Clinics